Cargando…

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation

AIMS: Undiagnosed atrial fibrillation (AF) accounts for 6% of all strokes, therefore early detection and treatment of the arrhythmia are paramount. Previous research has illustrated that the Microlife WatchBPO3 AFIB, an automated blood pressure (BP) monitor with an inbuilt AF algorithm, accurately d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huppertz, Nina, Lip, Gregory Y. H., Lane, Deirdre A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308245/ https://www.ncbi.nlm.nih.gov/pubmed/31701215 http://dx.doi.org/10.1007/s00392-019-01567-y

Ejemplares similares

EAM/FEMS launches microLife
por: Brakhage, Axel, et al.
Publicado: (2020)

Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting
por: Chan, Pak-Hei, et al.
Publicado: (2017)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)

Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
por: Ntaios, George, et al.
Publicado: (2023)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
por: Lane, Deirdre A., et al.
Publicado: (2018)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
por: Proietti, Marco, et al.
Publicado: (2020)

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
por: Lane, Deirdre A., et al.
Publicado: (2018)

Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry
por: Shantsila, Alena, et al.
Publicado: (2022)

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
por: Lane, Deirdre A., et al.
Publicado: (2017)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
por: Clarkesmith, Danielle E., et al.
Publicado: (2013)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
por: Proietti, Marco, et al.
Publicado: (2016)

Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
por: Proietti, Marco, et al.
Publicado: (2016)

Suppression of Paroxysmal Atrial Fibrillation by Pacing
por: Gupta, Anoop K
Publicado: (2003)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
por: Choi, Byung Joo, et al.
Publicado: (2012)

At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation
por: Leo, Donato Giuseppe, et al.
Publicado: (2023)

Questionable accuracy of home blood pressure measurements in the obese population – Validation of the Microlife WatchBP O3(®) and Omron RS6(®) devices according to the European Society of Hypertension-International Protocol
por: Azaki, Alaa, et al.
Publicado: (2017)

Wearable device for continuously blood pressure monitoring enable atrial fibrillation risk
por: Guo, Y, et al.
Publicado: (2022)

Prospective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation
por: Schmidt, Constanze, et al.
Publicado: (2020)

Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists
por: Zulkifly, Hanis H., et al.
Publicado: (2023)

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Balloon Cryoablation for the Treatment of Paroxysmal Atrial Fibrillation
por: Fenelon, Guilherme, et al.
Publicado: (2017)

Cryoballoon Ablation for Patients With Paroxysmal Atrial Fibrillation
por: Suenari, Kazuyoshi, et al.
Publicado: (2020)

Internationally validated score to predict the outcome of non-paroxysmal atrial fibrillation ablation: the ‘FLAME score’
por: Boyalla, Vennela, et al.
Publicado: (2021)

Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL‐AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
por: Lee, S R, et al.
Publicado: (2023)

The relationship between morning blood pressure surge and asymptomatic episodes of paroxysmal atrial fibrillation in patients with systemic arterial hypertension
por: TAŞ, Ümmü, et al.
Publicado: (2022)

What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?
por: Park, Yoon Jung, et al.
Publicado: (2020)

Detection of Atrial Fibrillation Using a Home Blood Pressure Monitor
por: Balanis, Thomas, et al.
Publicado: (2021)

Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review
por: Al Bahhawi, Tariq, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9416v73ltgk02bgvjls4jhqpjo